ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,407,218 | -80.9% | 20,227 | -71.4% | 0.00% | -81.8% |
| Q2 2023 | $12,585,912 | +2.1% | 70,632 | -5.4% | 0.02% | -4.3% |
| Q1 2023 | $12,323,002 | +1453.8% | 74,703 | +1383.4% | 0.02% | +1050.0% |
| Q4 2022 | $793,067 | -91.4% | 5,036 | -91.8% | 0.00% | -90.5% |
| Q3 2022 | $9,227,000 | +7.0% | 61,266 | +16.8% | 0.02% | +10.5% |
| Q2 2022 | $8,621,000 | +1165.9% | 52,446 | +1589.1% | 0.02% | +1800.0% |
| Q1 2022 | $681,000 | -15.0% | 3,105 | -8.0% | 0.00% | -50.0% |
| Q4 2021 | $801,000 | +35.3% | 3,374 | +33.1% | 0.00% | +100.0% |
| Q3 2021 | $592,000 | -6.9% | 2,535 | -18.0% | 0.00% | 0.0% |
| Q2 2021 | $636,000 | +38.6% | 3,091 | +38.5% | 0.00% | 0.0% |
| Q1 2021 | $459,000 | +28.2% | 2,232 | +33.7% | 0.00% | 0.0% |
| Q4 2020 | $358,000 | -60.3% | 1,670 | -66.1% | 0.00% | -66.7% |
| Q3 2020 | $901,000 | -9.4% | 4,928 | -8.3% | 0.00% | 0.0% |
| Q2 2020 | $995,000 | -4.2% | 5,374 | +4.3% | 0.00% | -25.0% |
| Q1 2020 | $1,039,000 | +19.2% | 5,150 | +10.5% | 0.00% | +33.3% |
| Q4 2019 | $872,000 | +17.5% | 4,660 | +0.2% | 0.00% | +50.0% |
| Q3 2019 | $742,000 | -37.9% | 4,651 | -1.9% | 0.00% | -50.0% |
| Q2 2019 | $1,194,000 | -22.8% | 4,741 | -26.6% | 0.00% | -20.0% |
| Q1 2019 | $1,547,000 | -37.8% | 6,462 | -33.1% | 0.01% | -44.4% |
| Q4 2018 | $2,488,000 | -10.4% | 9,656 | +1.6% | 0.01% | -10.0% |
| Q3 2018 | $2,777,000 | +2.2% | 9,505 | +2.7% | 0.01% | +11.1% |
| Q2 2018 | $2,718,000 | -33.7% | 9,255 | -43.0% | 0.01% | -43.8% |
| Q1 2018 | $4,100,000 | +14.9% | 16,241 | -1.6% | 0.02% | +33.3% |
| Q4 2017 | $3,567,000 | +27.0% | 16,512 | +9.3% | 0.01% | +20.0% |
| Q3 2017 | $2,808,000 | +4.6% | 15,109 | -2.9% | 0.01% | -9.1% |
| Q2 2017 | $2,684,000 | +23.3% | 15,559 | +9.2% | 0.01% | +10.0% |
| Q1 2017 | $2,176,000 | +12.5% | 14,244 | +8.5% | 0.01% | +11.1% |
| Q4 2016 | $1,935,000 | +61.0% | 13,130 | +38.2% | 0.01% | +50.0% |
| Q3 2016 | $1,202,000 | +39.9% | 9,503 | +24.6% | 0.01% | +20.0% |
| Q2 2016 | $859,000 | -14.7% | 7,625 | -21.2% | 0.01% | -16.7% |
| Q1 2016 | $1,007,000 | -7.3% | 9,676 | +0.5% | 0.01% | -14.3% |
| Q4 2015 | $1,086,000 | +42.3% | 9,629 | +38.1% | 0.01% | 0.0% |
| Q3 2015 | $763,000 | +53.5% | 6,972 | +34.3% | 0.01% | +75.0% |
| Q2 2015 | $497,000 | -1.6% | 5,193 | -4.1% | 0.00% | 0.0% |
| Q1 2015 | $505,000 | +13.2% | 5,417 | -0.6% | 0.00% | 0.0% |
| Q4 2014 | $446,000 | – | 5,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |